First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Stock Price Up 1% – Should You Buy?

Posted by Stephan Jacobs on Nov 12th, 2024

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) shares were up 1% during mid-day trading on Monday . The company traded as high as GBX 1,698.30 ($21.85) and last traded at GBX 1,698.30 ($21.85). Approximately 316 shares changed hands during trading, a decline of 82% from the average daily volume of 1,770 shares. The stock had previously closed at GBX 1,680.80 ($21.63).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 1.0 %

The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average price of GBX 1,589.06 and a 200-day moving average price of GBX 1,528.03. The firm has a market cap of £5.02 billion and a P/E ratio of -1,543.91.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.